SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer
SAFFRON-301:一项随机III期研究,评估sitravatinib联合tislelizumab治疗局部晚期或转移性非小细胞肺癌患者的疗效
期刊:
影响因子:
doi:10.1136/bmjonc-2025-000890
Zhou, Qing; Gao, Bo; Hu, Jie; Zhao, Jun; Wang, Mengzhao; He, Kai; Zhang, Wei; Liu, Chunling; Fang, Jian; Li, Xing Ya; Wang, Zhehai; Matos, Marco; Kwatra, Vineet; Zheng, Wenjuan; Wang, Chenyang; Chen, Yaxi; Zhang, Juan; Wang, Jun; Wu, Yi-Long